Actinium Pharmaceuticals, Inc. To Present At The 24th Annual Wall Street Analyst Forum Institutional Investor Conference
2/26/2014 10:23:38 AM
Actinium Pharmaceuticals, Inc. (OTCQB: ATNM.OB) ("Actinium" or "the Company"), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announces that Kaushik J. Dave, Ph.D., President and CEO, will present at the 24th Annual Wall Street Analyst Forum Institutional Investor Conference at the University Club of New York, located at 1 West 54th Street, New York, NY, on Monday, March 3, 2014 at 9:05 AM ET.
Help employers find you! Check out all the jobs and post your resume.
comments powered by